Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related BMY
The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Benzinga's Top Upgrades, Downgrades For December 6, 2018
Cancer Research Highlight: Curtains Begin To Close On AbbVie's Small Cell Program (Seeking Alpha)
Related HOG
Snapping Back, But Can Rally Attempt Last? Strong Earnings Might Power Market
A Peek Into The Markets: US Stock Futures Tumble Ahead Of Earnings

Analysts at Barclays downgraded Bristol-Myers Squibb Company (NYSE: BMY) from “overweight” to “equal-weight.” The target price for Bristol-Myers Squibb has been lowered from $65 to $46. Bristol-Myers Squibb's shares closed at $48.12 yesterday.

Analysts at Raymond James downgraded Harley-Davidson (NYSE: HOG) from “strong buy” to “market perform” and removed the price target of $84. Harley-Davidson's shares closed at $70.33 yesterday.

Baird downgraded U.S. Bancorp (NYSE: USB) from “outperform” to “neutral.” The price target for U.S. Bancorp is set to $44. U.S. Bancorp's shares closed at $43.34 yesterday.

Credit Suisse downgraded Hormel Foods (NYSE: HRL) from “outperform” to “neutral.” Hormel's shares closed at $49.19 yesterday.

Latest Ratings for BMY

Dec 2018BMO CapitalUpgradesMarket PerformOutperform
Nov 2018BMO CapitalMaintainsMarket PerformMarket Perform
Nov 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight

View More Analyst Ratings for BMY
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (BMY + HOG)

View Comments and Join the Discussion!

Latest Ratings

BAPItau BBAUpgrades274.0
DVNJP MorganDowngrades37.0
EOGJP MorganUpgrades118.0
EXPDGoldman SachsDowngrades68.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: Constellation Brands Posts Upbeat Q1 Earnings, Shares Surge

UPDATE: Keefe, Bruyette & Woods Downgrades Independent Bank As Focus Turns To Rebuilding Profitability